WebJul 15, 2024 · Overall use and modification of GDMT, which included heart failure appropriate beta-blockers (BB), renin-angiotensin system inhibitors (RASi) and aldosterone blockers (MRA) during the hospitalization were collected. Target dosages were based on guideline recommendations. WebApr 30, 2024 · This study found that pharmacist-led medication optimization increased the use of GDMT in ambulatory patients with HF, and may be associated with fewer hospitalizations and deaths. Future randomized controlled trials should evaluate the impact of adding pharmacist-led HF medication optimization to standard of care on clinical …
Optimizing GDMT for HFrEF During Hospitalization - USC …
WebNov 17, 2024 · Older patients are underrepresented in clinical trials in HF, and aggressive uptitration of GDMT in older patients is often limited by comorbidities, frailty, and polypharmacy. The article by Martinez et al 4 reports the efficacy and tolerability of dapagliflozin stratified by age group. WebAug 7, 2024 · GDMT refers to initial medical therapy with angiotensin-converting enzyme inhibitors (ACEi) or angiotensin-receptor blockers (ARB), beta-blockers (BB), and mineralocorticoid receptor antagonists (MRA) titrating to maximally tolerated doses for patients with HFrEF. graphtec ce6000 automatic width measurement
Optimizing Initiation of GDMT for Heart F…
WebApr 12, 2024 · Clinical utility of natriuretic peptides in the optimization of GDMT in the acute HF patient population; Have greater competence related to Application of the latest evidence for the rapid uptitration of GDMT in appropriate patients with acute HF; Demonstrate greater confidence in their ability to ... WebOptimal pharmacologic therapy of heart failure with reduced ejection fraction (HFrEF) is carefully scripted by evidence-based treatment guidelines, 1,2 but a large proportion of patients with chronic HFrEF either … WebApr 1, 2024 · Story Health is a company designed to interface with electronic medical records and provide a link between clinicians and patients to optimize GDMT. We aim to assess the effectiveness of Story Health GDMT optimization of patients with HFrEF in achieving > 50% of target dose at 90 days. chiswick antenatal classes